Management of schizophrenia with obesity, metabolic, and endocrinological disorders.Palmiero Monteleone, Vassilis Martiadis, Mario MajThe Psychiatric clinics of North America2009
The metabolic effects of antipsychotic medications.John W Newcomer, Dan W HauptCanadian journal of psychiatry. Revue canadienne…2006
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States.John B Buse, Patrizia Cavazzoni, Kenneth Hornbuckle, David Hutchins, Alan Breier, Lois JovanovicJournal of clinical epidemiology20031 Excerpt
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.Jean-Pierre Lindenmayer, Pal Czobor, +6 authors Jeffrey A LiebermanThe American journal of psychiatry2003
An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.Carol E Koro, Donald O Fedder, +5 authors Robert W BuchananArchives of general psychiatry2002
Prevalence of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine.P Leonard, A Halley, S BrowneIrish medical journal2002